NCT06800755

Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Pierre Fabre Dermo Cosmetique · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The product RL3020-DP0364 developed by Pierre Fabre Laboratories moisturizes durably and repairs dry or atopic skin, especially in the case of certain dermatoses (atopic dermatitis, ichthyosis, etc ...) and erythema induced by radiotherapy. Its unique formula treats the symptoms of dry skin by creating a protective film that prevents dehydration and helps protect the skin from external aggressions. Through this study, the efficacy of this medical device will be evaluated specifically in subjects presenting stable psoriasis, dry skin and pruritus with an application on the whole body (excluding the head).

Conditions

• Psoriasis
• Pruritus
• Dry Skin

Interventions

Type	Name	Description
DEVICE	Dexeryl (RL3020-DP0364)	Product application on body (head excluded)

Timeline

• Start date: 2025-02-27
• Primary completion: 2025-07-04
• Completion: 2025-07-04
• First posted: 2025-01-30
• Last updated: 2025-04-01

Locations

1 site across 1 country: Poland